MARBLE: Multi-Agent Reasoning for Bioinformatics Learning and Evolution
Sunghyun Kim, Seokwoo Yun, Youngseo Yun, Youngrak Lee, Sangsoo Lim

TL;DR
MARBLE is a framework that enables stable, iterative refinement of bioinformatics models through structured debate, empirical evaluation, and memory updates, improving performance while ensuring robustness.
Contribution
It introduces a novel autonomous model refinement framework combining literature-aware reference selection, debate-driven reasoning, and performance-grounded updates for bioinformatics models.
Findings
Consistently improves performance across multiple bioinformatics tasks.
Maintains high robustness and low regression during iterative refinement.
Structured debate and memory are key for stable model evolution.
Abstract
Motivation: Developing high-performing bioinformatics models typically requires repeated cycles of hypothesis formulation, architectural redesign, and empirical validation, making progress slow, labor-intensive, and difficult to reproduce. Although recent LLM-based assistants can automate isolated steps, they lack performance-grounded reasoning and stability-aware mechanisms required for reliable, iterative model improvement in bioinformatics workflows. Results: We introduce MARBLE, an execution-stable autonomous model refinement framework for bioinformatics models. MARBLE couples literature-aware reference selection with structured, debate-driven architectural reasoning among role-specialized agents, followed by autonomous execution, evaluation, and memory updates explicitly grounded in empirical performance. Across spatial transcriptomics domain segmentation, drug-target interaction…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBioinformatics and Genomic Networks · Computational Drug Discovery Methods · Genomics and Rare Diseases
